TITLE

PATENTS: It's good to share

AUTHOR(S)
Giles, Jim
PUB. DATE
April 2009
SOURCE
Prospect;Apr2009, Issue 157, p66
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the reputation of pharmaceutical companies and plans to implement a patent pool system. The author suggests that the system would allow companies to share intellectual property and develop affordable drugs to treat diseases in developing countries. Other topics include neglected diseases, the cost of research, and moral aspects of the pharmaceutical industry.
ACCESSION #
40102173

 

Related Articles

  • Drug patent plan gets mixed reviews. Butler, Declan // Nature;2/26/2009, Vol. 457 Issue 7233, p1 

    The article discusses the reaction to U.S. pharmaceutical company GlaxoSmithKline's (GSK) decision to share some of its patents to increase research efforts into neglected diseases and make its drugs available to the poorest countries through cheaper prices. Topics include an explanation of a...

  • New deal from the World Trade Organisation. Pollock, Allyson M.; Price, David // BMJ: British Medical Journal (International Edition);9/13/2003, Vol. 327 Issue 7415, p571 

    Reports on the supposed resolution of the issue of giving poor countries access to essential medicines without breaching laws on intellectual property by the World Trade Organization (WTO). Past agreements; Allowance of drug companies to charge monopoly prices for essential drugs; Provisions for...

  • Pharmaceuticals and intellectual property rights: A political economy of the recent policy changes across the developing world and in Turkey. Vural, ─░pek Eren // Middle East Technical University Studies in Development;Dec2007, Vol. 34 Issue 2, p337 

    This paper explores the sources of the recent policy changes from weaker to stronger intellectual property regimes (IPRs) for pharmaceuticals across the developing world, and in Turkey. Analysing the policy change from a political economy approach, the paper argues that the increased structural...

  • The patentability of medicinal inventions related to personalized medicine in Japan. Shimbo, Itsuki; Cobden, Andrew; Sumikura, Koichi // Nature Biotechnology;Nov2005, Vol. 23 Issue 11, p1367 

    Reports on the several amendments of the examination guidelines for medicinal inventions in Japan. Possibility of obtaining a patent for a medicinal innovation by specifying the class of patients; Protection of the combinations of medicines and optimization of dosage and frequency of...

  • Pharma patents: India ranks second.  // Siliconindia;Sep2005, Vol. 9 Issue 8, p15 

    Reports on the increasing number of applications for patent of pharmaceutical products in India. Invention of critical life saving drugs by the pharmaceutical companies; Launch of drugs at a frenetic pace in Western countries; Attraction of international attention by the pharmaceutical firms...

  • Patent policy and public health in developing countries: lessons from Japan. Aoki, Reiko; Kubo, Kensuke; Yamane, Hiroko // Bulletin of the World Health Organization;May2006, Vol. 84 Issue 5, p417 

    The article discusses on the implications of the World Trade Organization's Trade-Related Aspects of Intellectual Property Rights Agreement on the public health sector in developing countries. Under the product patent law, local pharmaceutical companies are restricted to copy manufactured drugs...

  • Patent sense. Herrling, Paul // Nature;9/13/2007, Vol. 449 Issue 7159, p174 

    The article discusses the importance of protecting intellectual property with patents for pharmaceutical companies to discover and develop new drugs for the developing countries. A patent is defined as a grant by the state of exclusive rights for a limited time in respect of a new and useful...

  • Drug firms use legal loopholes to safeguard brand names. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);08/05/2000, Vol. 321 Issue 7257, p320 

    Focuses on a report from the National Institute for Health Care Management on the efforts of United States pharmaceutical companies to extend the life of patents for lucrative drugs. How the extension of intellectual property protections prevents the entrance of inexpensive generic drugs into...

  • Patents, Innovation and Access to New Pharmaceuticals. Grabowski, Henry // Journal of International Economic Law;Dec2002, Vol. 5 Issue 4, p849 

    This paper considers the role of intellectual property rights in the development of, and access to, new pharmaceuticals. A number of studies have found patents are significantly more important to pharmaceutical firms in appropriating the benefits from innovation compared with other high tech...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics